John R. Stuelpnagel - Jun 3, 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for John R. Stuelpnagel
Stock symbol
TXG
Transactions as of
Jun 3, 2025
Transactions value $
$0
Form type
4
Date filed
6/5/2025, 05:22 PM
Previous filing
Jun 13, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
STUELPNAGEL JOHN R Director C/O 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Eric S. Whitaker, as Attorney-in-Fact for John R. Stuelpnagel 2025-06-05 0001189140

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Award $0 +15.4K +4.46% $0.00 360K Jun 3, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date.